NVIDIA plans investment in AI biology company Prima Mente
Prima Mente builds biological foundation models, with an initial focus on the brain.
Planned strategic investment
NVIDIA named Prima Mente among its planned UK startup investments on October 13, 2026. The announcement disclosed no investment amount or closing date.
What Prima Mente builds
Prima Mente combines biological data generation with general-purpose foundation models to support research and clinical applications. Its initial focus is understanding the brain and neurological disease, bringing AI research together with experimental science and clinical questions.
Its team works across London, San Francisco and the UAE.